Prognostic and predictive value of VEGF, sVEGFR-2 and CEA in mCRC studies comparing cediranib, bevacizumab and chemotherapy

BACKGROUND: The prognostic/predictive value of potential vascular endothelial growth factor (VEGF) signalling biomarkers was evaluated retrospectively using samples from two randomized Phase III studies (HORIZON II and III) investigating cediranib in metastatic colorectal cancer (mCRC). METHODS: Bas...

Descripción completa

Detalles Bibliográficos
Autores principales: Jürgensmeier, J M, Schmoll, H-J, Robertson, J D, Brooks, L, Taboada, M, Morgan, S R, Wilson, D, Hoff, P M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3619270/
https://www.ncbi.nlm.nih.gov/pubmed/23449351
http://dx.doi.org/10.1038/bjc.2013.79

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3619270/
https://www.ncbi.nlm.nih.gov/pubmed/23449351
http://dx.doi.org/10.1038/bjc.2013.79

Ejemplares similares